Program Description
Demodex blepharitis is a chronic eyelid disease caused by mite infestation. Though this condition affects millions of people in the United States, it is frequently underdiagnosed or misdiagnosed, contributing to substantial clinical and economic burden. Historically managed with limited, off-label therapies and over-the-counter options, the approval of targeted agents signals new approaches to management and patients' ocular health outcomes. This webinar specifically focuses on evidence-based clinical updates and strategic tools necessary for managed care professionals and pharmacists to navigate this shifting landscape. Recent data evaluating health care resource utilization will be analyzed and used to inform the development of strategies to mitigate access barriers, including optimizing prior authorization and step therapy processes, to reduce the systemic costs associated with delayed or suboptimal treatment for patients with Demodex blepharitis.
Target audience: Managed Care Pharmacists
Type of activity: Application
Release date: September
16, 2026
Expiration date: November 16, 2026
Time
to complete activity: 1 hour
Learner level: Foundational,
Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explore the clinical burden and presentation of Demodex blepharitis, with emphasis on the physical, psychological, and financial challenges experienced by patients
- Explain mechanisms of action, efficacy and safety profiles, and limitations or adherence challenges associated with traditional management strategies and newly approved targeted therapies in Demodex blepharitis
- Identify the economic burden of Demodex blepharitis and strategies to enhance access to targeted therapy, including approaches to reduce administrative and coverage-related barriers
Abby Singleton, PharmD, BCPS
Senior Pharmacist, Clinical Pharmacy Strategies
Highmark Inc.
Pittsburgh, PA
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number UAN is 0290-0000-26-247-H01-P. The activity is available for CE credit through November 16, 2026.
Instructions for Completing the Activity and Receiving CPE Credit
To
receive CPE credit, participants must complete the pretest, review the activity in
its entirety, complete the posttest, and complete the online activity
evaluation. After successful completion of the online activity evaluation, you
can submit your credit to CPE Monitor. You may view your credit within 48 hours
at www.mycpemonitor.net. All participants must request credit before the
activity expiration date. CE credit will not be issued after this date.
Disclosures
Abby Singleton, PharmD, BCPS, has no relevant financial relationships with ineligible companies to disclose.
Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Adam C. Welch, PharmD, MBA, FAPhA; Sarah Viruet; and Brianna Winters have no financial relationships with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
At least 1 anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms